CANCER-TREATING AGENT THAT TARGETS AT LONG-CHAIN NON-CODING RNA, AND CANCER DIAGNOSIS METHOD

摘要

In the present description, a cancer-treating agent is provided, which contains at least one component selected from a TM4SF1AS1 expression inhibitor, a PURA expression inhibitor and a YB1 expression inhibitor.